Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06488092 · ClinicalTrials.gov registry record · NA
IC-CS Risk: Patient Outcomes
A NA study of Cesarean Delivery, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 20,000
- Enrollment target
- 14
- Study locations
NCT06488092: Active NA study of Cesarean Delivery, sponsored by University of Pennsylvania.
NCT06488092 is a NA study of Cesarean Delivery that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 20,000 participants, above the 1,483-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (1249% higher). The trial reports 14 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06488092, a NA study of Cesarean Delivery, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20,000 participants
- Enrollment target
- 14
- Study locations
Study Summary
This study is looking at the impact of the implementation of a cesarean risk calculator on cesarean delivery and maternal morbidity rates.
Conditions Studied
Interventions
- OTHER Cesarean Risk Calculator
Study Locations (14)
Michigan
- University of Michigan - Ann Arbor
- Henry Ford Macomb Hospital - Clinton Township
- Henry Ford Hospital - Detroit
- E.W. Sparrow Hospital - Lansing
Utah
- Logan Regional Hospital-Intermountain Healthcare - Logan
- McKay-Dee Hospital - Ogden
- Riverton Hospital-Intermountain Healthcare - Riverton
- University of Utah Hospital - Salt Lake City
Ohio
- Akron General - Akron
- Fairview Hospital - Cleveland
- Hillcrest Hospital - Mayfield Heights
Pennsylvania
- Lancaster General Health - Lancaster
- Chester County Hosptial - West Chester
New Jersey
- Princeton Medical Center - Plainsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2027-09 |
| Phase | NA |
What the registry record for NCT06488092 still lists
NCT06488092 is an interventional study that assigns participants to a tested intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,483-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (1249% higher).
The record links to 1 condition, with Cesarean Delivery appearing as the primary indexed condition, and to 1 intervention - of which Cesarean Risk Calculator is the first listed.
NCT06488092 lists 14 locations in 5 states (Michigan, Utah, Ohio).
Frequently Asked Questions
What is clinical trial NCT06488092 about?
NCT06488092 is a clinical study titled "IC-CS Risk: Patient Outcomes". This study is looking at the impact of the implementation of a cesarean risk calculator on cesarean delivery and maternal morbidity rates.
What is the current status of trial NCT06488092?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20,000 participants. The study started on 2024-09-01. Estimated completion is 2027-09.
What conditions does trial NCT06488092 study?
This clinical trial studies the following conditions: Cesarean Delivery.
What interventions are being tested in trial NCT06488092?
The interventions under investigation include: Cesarean Risk Calculator (OTHER).
Who is sponsoring clinical trial NCT06488092?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06488092 being conducted?
This trial has 14 study locations across Michigan, New Jersey, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Delivery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06488092's enrollment target sits among peer trials
20,000 1st of 10 higher than 10 of 10 other Cesarean Delivery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Delivery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-Operative Cesarean Section Cosmesis
RECRUITING · NA
-
Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin
RECRUITING · NA
-
Delayed Cord Clamping at Term Cesarean
COMPLETED · NA
-
COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block
RECRUITING · Phase 4
-
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
RECRUITING
-
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI